Search

Your search keyword '"Mitsura, V"' showing total 102 results

Search Constraints

Start Over You searched for: Author "Mitsura, V" Remove constraint Author: "Mitsura, V"
102 results on '"Mitsura, V"'

Search Results

1. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

2. Healthcare delivery for HIV-positive people with tuberculosis in Europe

3. Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality—a multicentre prospective cohort study

4. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

5. Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European Cohort

6. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study

7. Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality-a multicentre prospective cohort study

10. Observational cohort study of rilpivirine (RPV) utilization in Europe

11. HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe

13. Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

14. Healthcare delivery for HIV-positive people with tuberculosis in Europe

15. Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe:associated factors and effect on mortality—a multicentre prospective cohort study

16. Healthcare delivery for HIV-positive people with tuberculosis in Europe

17. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA

18. Healthcare delivery for HIV-positive people with tuberculosis in Europe

19. Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe

21. Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy

25. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens

26. Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in Europe

28. Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort

29. The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people

31. Liver-related death among HIV/hepatitis C virus-co-infected individuals

32. Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression : A prospective cohort study

33. Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study

34. Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe

35. Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe

36. RESULTS OF THE USE OF SOFOSBUVIR IN COMBINATION WITH LEDIPASVIR OR DACLATASVIR FOR CHRONIC HEPATITIS C TREATMENT IN THE REPUBLIC OF BELARUS

38. Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study

39. Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study

40. Infection-related and -unrelated malignancies, HIV and the aging population

41. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: An international cohort study

44. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study

45. Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients

46. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

47. Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study

48. Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations

49. Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe

Catalog

Books, media, physical & digital resources